Skip to main content
Clinical Trials/JPRN-UMIN000015194
JPRN-UMIN000015194
Completed
N/A

Evaluation of Chromosomal Genetic Abnormalities in Cells in Urine Using UroVysion - UroVysion Domestic Japanese Clinical Performance Trial

roVysion Domestic Japanese Clinical Performance Trial Steering Committee0 sites450 target enrollmentSeptember 17, 2014
ConditionsBladder cancer

Overview

Phase
N/A
Intervention
Not specified
Conditions
Bladder cancer
Sponsor
roVysion Domestic Japanese Clinical Performance Trial Steering Committee
Enrollment
450
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 17, 2014
End Date
TBD
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
roVysion Domestic Japanese Clinical Performance Trial Steering Committee

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients who may be unable to make the follow\-up hospital visits Patients who now have or previously have demonstrable upper urinary tract cancer (renal pelvis or ureter cancer) or urethral cancer (including prostatic urethral cancer) Patients who have already participated in the trial once

Outcomes

Primary Outcomes

Not specified

Similar Trials